Treatment algorithm in patients with MF. alloHSCT, allogeneic hematopoietic stem cell transplantation; AP/BP, accelerated phase/blast phase; DIPSS, Dynamic International Prognostic Scoring System; ESA, erythropoiesis-stimulating agents; GIPSS, Genetically Inspired Prognostic Scoring System for Primary Myelofibrosis; HU, hydroxyurea; MIPSS70+v2.0, Mutation-Enhanced International Prognostic Scoring System 70 plus version 2.0; MYSEC-PM, Myelofibrosis Secondary to PV and ET Prognostic Model; Pred, prednisolone; Thal, thalidomide; Ven, venetoclax.